StockData
Vir Biotechnology, Inc. logo

Vir Biotechnology, Inc. (VIR) stock

VIRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3030% below fair value
$9.15−0.10 (-1.08%)

Close on Nov 18, 2026Market cap $1.55BP/E –Yield –

Vir Biotechnology revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Vir Biotechnology's revenue for the twelve months ending Jun 30, 2026 was $303.23M, up 1495.9% year over year. For fiscal 2025 it was $68.56M, down 7.6% from the year before. The highest annual figure on record is $1.62B in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$68.56M-7.6%
FY2024Dec 31, 2024$74.21M-13.9%
FY2023Dec 31, 2023$86.18M-94.7%
FY2022Dec 31, 2022$1.62B+47.5%
FY2021Dec 31, 2021$1.10B+1334.4%
FY2020Dec 31, 2020$76.37M+843.9%
FY2019Dec 31, 2019$8.09M-24.2%
FY2018Dec 31, 2018$10.67M+293.9%
FY2017Dec 31, 2017$2.71M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$238.95M+19582.5%
Q1 FY2026Mar 31, 2026-$29.00K-101.0%
Q4 FY2025Dec 31, 2025$64.07M+417.8%
Q3 FY2025Sep 30, 2025$240.00K-89.9%
Q2 FY2025Jun 30, 2025$1.21M-60.5%
Q1 FY2025Mar 31, 2025$3.03M-94.6%
Q4 FY2024Dec 31, 2024$12.37M-26.3%
Q3 FY2024Sep 30, 2024$2.38M-9.8%
Q2 FY2024Jun 30, 2024$3.08M-19.0%
Q1 FY2024Mar 31, 2024$56.38M-10.5%
Q4 FY2023Dec 31, 2023$16.79M-66.0%
Q3 FY2023Sep 30, 2023$2.64M-99.3%
Q2 FY2023Jun 30, 2023$3.80M–
Q1 FY2023Mar 31, 2023$62.96M-94.9%
Q4 FY2022Dec 31, 2022$49.41M-93.9%
Q3 FY2022Sep 30, 2022$374.56M+261.5%
Q2 FY2022Jun 30, 2022-$40.63M-122.9%
Q1 FY2022Mar 31, 2022$1.23B+62271.4%
Q4 FY2021Dec 31, 2021$812.75M+46771.2%
Q3 FY2021Sep 30, 2021$103.62M+5274.3%
Q2 FY2021Jun 30, 2021$177.07M+164.3%
Q1 FY2021Mar 31, 2021$1.98M-65.4%
Q4 FY2020Dec 31, 2020$1.73M+76.9%
Q3 FY2020Sep 30, 2020$1.93M+37.4%
Q2 FY2020Jun 30, 2020$66.99M+3172.5%
Q1 FY2020Mar 31, 2020$5.72M+56.2%
Q4 FY2019Dec 31, 2019$980.00K-68.7%
Q3 FY2019Sep 30, 2019$1.40M-51.4%
Q2 FY2019Jun 30, 2019$2.05M-8.0%
Q1 FY2019Mar 31, 2019$3.66M+50.5%
Q4 FY2018Dec 31, 2018$3.13M–
Q3 FY2018Sep 30, 2018$2.89M–
Q2 FY2018Jun 30, 2018$2.22M–
Q1 FY2018Mar 31, 2018$2.43M–

More Vir Biotechnology figures

See a number that looks wrong?